OSE Immunotherapeutics Announces Procedures for Virtual Combined General Meeting

Regulatory News:

OSE Immunotherapeutics (Paris:OSE) (ISIN: FR0012127173; Mnémo: OSE) announces the procedures for participating to the Combined General Meeting, to be held on June 16, 2020 at 2:30 p.m. CET.

As indicated in the press release dated May 11, 2020, the Combined General Meeting of June 16, 2020, will be held by live webcast, without the physical presence of shareholders or other persons usually eligible to attend pursuant to the provisions of the ordinances dated March 25, 2020.

The prior notice to the General Meeting including the agenda, the resolutions submitted for approval and the main methods of participation and voting, and also serving as notice of the meeting, was published on May 8, 2020 in the French bulletin of mandatory legal announcements (BALO).

• Login information

The General Meeting will be webcast live (in French) via a web conferencing system and shareholders of OSE Immunotherapeutics are invited to login through the link:

https://channel.royalcast.com/webcast/oseimmunotherapeutics/20200616_1 ...

This link allows shareholders to register for the General Meeting as of today (and until June 16 at 2 p.m. CET) by entering their email address. Registrants will receive a registration confirmation in addition to the ability to add the event to their calendar.

On June 16, 2020, shareholders will be able to connect via this same link starting at 2 p.m. CET. The General Meeting will start at 2.30 p.m. and attendees will be able to follow the presentation by OSE Immunotherapeutics’ management on their screens.

Due to the closed session, it will not be possible for shareholders to amend resolutions or to propose new resolutions during the General Meeting. The shareholders retain their right to request the inclusion of items or draft resolutions on the agenda and to ask written questions before the General Meeting, in accordance with the regulations in force. Shareholders are invited to send their questions from today and at any time during the presentation to the email address: [e-mail]. They will be answered during the General Meeting's Q&A session.

• Appointment of scrutineers

In accordance with Decree No. 2020-418, the Company’s Board of Directors has decided to appoint the following shareholders as scrutineers:

- Mrs. Maryvonne Hiance, shareholder and Vice-Chairman of the Board of Directors;

- Mr. Alexis Peyroles, shareholder and CEO of the Company.

The General Meeting will be chaired by Mrs. Dominique Costantini, President of the Board of Directors.